Table 3.

Main messages arising from the latest KDIGO review of the guidelines on CKD-MBD management [16, 17]

KDIGO guidelines
It is important to evaluate the set of biochemical markers as a whole and their trends in time
Hypercalcemia should be avoided
Calcimimetics are among first choice options to consider in stage-5D CKD patients